White label ELPA - ClinicalTrials.eu

Study of Darolutamide and Testosterone for Patients with Advanced Prostate Cancer Resistant to Standard Hormone Therapy

Recruiting

2 1 1 1
Investigated Drugs:
Evaluating Somatostatin Receptor 2 Expression Using [68Ga]Ga-DOTA-TOC PET/CT Imaging in Patients with Epstein-Barr Virus Associated Nasopharyngeal Carcinoma

Recruiting

1 1 1
Investigated Diseases:
- Nasopharyngeal cancer
Study of Cemiplimab Combined with Imiquimod and Laser Therapy Before Surgery for High-Risk Skin Basal Cell Carcinoma

Recruiting

1 1 1 1
Investigated Diseases:
- Basal cell carcinoma
Investigated Drugs:
- Imiquimod
- Cemiplimab
Preoperative Elacestrant and PULSAR Adaptive Radiotherapy for Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Study for Patients with Stage II-III Disease

Recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Effectiveness of Macrogol 3350 With Electrolytes and Sodium Picosulfate/Magnesium Citrate Combination for Bowel Preparation in Patients With Inadequate Previous Colonoscopy Preparation

Recruiting

3 1 1
Investigated Drugs:
Study on Sentinel Lymph Node Technique in Early-Stage Ovarian Cancer Using Pertechnetate (99mTc) Sodium, Human Serum Albumin, and Indocyanine Green

Recruiting

3 1 1 1
Investigated Drugs:
Evaluating Citrulline, Folic Acid, Vericiguat, and Tadalafil Combination for Patients with Treatment-Resistant High Blood Pressure

Recruiting

2 1 1 1
Investigated Diseases:
- Hypertension
Investigated Drugs:
Study on the Safety and Effects of EIK1004 for Patients with Advanced Solid Tumors

Recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Reduced Immunosuppression Therapy Trial for Elderly Kidney Transplant Recipients with End-Stage Renal Disease

Recruiting

3 1 1 1
Investigated Diseases:
- End stage renal disease
Investigated Drugs:
Evaluation of Botulinum Toxin Injections for Women with Severe Primary Dysmenorrhea Unresponsive to First-Line Treatments

Recruiting

3 1 1
Investigated Drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies